Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Healthcare Costs
1,741-1,760 of 1,949 results
-
-
New Health Plans Expose The Insured To More Risk
Well-known insurers are offering plans with lower premiums. But they could leave patients on the hook for unexpected costs.
-
How Much Difference Will Eli Lilly’s Half-Price Insulin Make?
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
As Hospitals Post Price Lists, Consumers Are Asked To Check Up On Them
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
-
Lawmakers United Against High Drug Prices Bare Partisan Teeth
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
By Rachel Bluth -
Podcast: KHN’s ‘What The Health?’ What’s Next For The FDA?
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
-
Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
-
This Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills
New research shows how an experience with surprise medical bills can guide patients’ future decision-making.
By Rachel Bluth -
Texas Lawmakers Take Aim At Surprise Medical Bills
A proposed state law with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills — instead of relying on patients to start the mediation process. The KHN/NPR "Bill of the Month" series is a catalyst for the effort.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Watch: Big Week For Drug Pricing Debate Featured On C-SPAN
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.
-
Americans Ready To Crack Down On Drug Prices That Force Some To Skip Doses
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
By Jay Hancock -
There’s A New ‘Medicare-For-All’ Bill In The House. Why Does It Matter?
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nation’s health system, and Democratic primary candidates will have to be prepared to get more specific.
-
Meow-ch! The $48,512 Cat Bite
An animal lover stopped to feed a hungry-looking stray cat outside Everglades National Park in Florida. First, the cat bit her finger — then the hospital billed her close to $50,000 for a treatment that typically costs about $3,000.
-
Cancer’s Complications: Confusing Bills, Maddening Errors And Endless Phone Calls
Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.
By Anna Gorman -
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
By Emmarie Huetteman and Jay Hancock -
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
By Emmarie Huetteman and Jay Hancock -
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.
By Shefali Luthra and Phil Galewitz -
Video: High Drama No Stranger At Congressional Health Care Hearings
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
By Julie Rovner and Mary Agnes Carey